Skip to content

Clinical trials

Terminated Bacteremia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacteremia Status: Terminated Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20091
20101
20111
20121
20141
20151
20171
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
AbbVie1
Beth Israel Medical Center1
CAMC Health System1
Cumberland Pharmaceuticals1
East Carolina University1
Henry Ford Health System1
MicroPhage, Inc.1
Pfizer1
University of Maryland, Baltimore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacteremia12
Endocarditis4
Staphylococcal Infections4
Gram-Positive Bacterial Infections3
Arthritis, Infectious2
Pneumonia2
Catheter-Related Infections1
Cystitis1
Disease1
Endocarditis, Bacterial1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.